The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Diabetes

• Publication date

  1977-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.26.4.314PMID 849812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dominant inheritance of large molecular weight immunoreactive glucagon.

  1978cited by this paper
• The Banting Memorial Lecture 1975: Diabetes and the Alpha Cell

  1976cited by this paper
• Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.

  1975cited by this paper
• Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide.

  1974cited by this paper
• Suppression of Pancreatic Glucagon Secretion by Tolbutamide in Dogs*

  1974cited by this paper
• Effects of Hypoglycemic Sulfonamides on Glucagon and Insulin Secretion in Ducks and Dogs

  1974cited by this paper
• Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

  1974cited by this paper
• Stimulation of glucagon secretion by epinephrine in man.

  1973cited by this paper
• Failure of Sulfonylureas to Suppress Plasma Glucagon in Man

  1972cited by this paper
• Labeling of Oral Hypoglycemic Drugs

  1972cited by this paper
• Effects of Tolbutamide on Insulin and Glucagon Secretion of the Isolated Perfused Rat Pancreas*

  1971cited by this paper
• Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes

  1970cited by this paper
• Studies of pancreatic alpha cell function in normal and diabetic subjects.

  1970cited by this paper
• Effect of Blood Glucose on Glucagon Secretion in Anesthetized Dogs

  1969cited by this paper
• The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

  1968cited by this paper
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

  1967cited by this paper
• The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes.

  1966cited by this paper
• An immunochemical assay of total extractable insulin in man.

  1960cited by this paper

• THE ROLE OF GLUCAGON IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF DIABETES.

  2016cites this paper
• Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.

  2009cites this paper
• Overview of the Gliptin Class (Dipeptidyl Peptidase-4 Inhibitors) in Clinical Practice

  2009cites this paper
• [Sulfonyl urea compounds in diabetes therapy 1981. Arguments for a reasonable use].

  2008cites this paper
• Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.

  2007cites this paper
• α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains.

  2007cites this paper
• 388 EFFECTS OF GLIMEPIRIDE AND GLYBURIDE ON GLUCOSE COUNTERREGULATION AND RECOVERY FROM HYPOGLYCEMIA

  2005cites this paper
• Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study

  2004cites this paper
• Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine

  2004cites this paper
• Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone

  2004cites this paper
• Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics

  2004cites this paper
• Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.

  1999cites this paper
• Nonsteroidal anti-inflammatories (NSAIDS), oral hypoglycemics, and topical steroids. An overview.

  1998cites this paper
• Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.

  1996cites this paper
• Clinical Pharmacology of Sulfonylureas

  1996cites this paper
• Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations

  1996cites this paper
• A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin

  1995cites this paper
• Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.

  1994cites this paper
• Gliclazide directly suppresses arginine-induced glucagon secretion.

  1994cites this paper
• Sulfonylureas in NIDDM

  1992cites this paper
• Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.

  1992cites this paper
• Type II diabetes and syndrome X. Pathogenesis and glycemic management.

  1992cites this paper
• Hypoglycemic drugs.

  1992cites this paper
• Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone

  1992cites this paper
• Hepatic sensitivity to insulin: effects of sulfonylurea drugs.

  1991cites this paper
• The Management of Diabetes Mellitus in Older Individuals

  1991cites this paper
• Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?

  1991cites this paper
• Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.

  1991cites this paper
• [Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics].

  1990cites this paper
• Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients

  1990cites this paper
• Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with Type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin

  1989cites this paper
• Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

  1989cites this paper
• Oral hypoglycemic agents.

  1989cites this paper
• The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.

  1989cites this paper
• Effect of Oral Antidiabetic Drug Withdrawal in Type 2 Diabetes

  1989cites this paper
• Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients

  1987cites this paper
• Why is there still Disagreement over Insulin Secretion in Non‐insulin‐dependent Diabetes?

  1986cites this paper
• Oral sulfonylureas for the treatment of type II diabetes: an update.

  1986cites this paper
• Insulin secretion in noninsulin-dependent Diabetes Mellitus

  1986cites this paper
• Sulphonylurea therapy doubles B-cell response to glucose in Type 2 diabetic patients

  1985cites this paper
• The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects

  1984cites this paper
• Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy

  1984cites this paper
• Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.

  1984cites this paper
• Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.

  1984cites this paper
• Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.

  1984cites this paper
• Metabolic effects of sulfonylurea drugs. A review.

  1983cites this paper
• Approaches to novel antidiabetic therapy.

  1983cites this paper
• Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.

  1983cites this paper
• Pharmacologic Compounds Affecting Glucagon Secretion

  1983cites this paper
• New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.

  1983cites this paper
• Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.

  1982cites this paper
• Insulin Responses to Nonglucose Stimuli in Non-insulin-dependent Diabetes Mellitus During a Tolbutamide Infusion

  1982cites this paper
• Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.

  1982cites this paper
• The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes

  1982cites this paper
• Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.

  1981cites this paper
• Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.

  1981cites this paper
• Clinical Pharmacology of Sulphonylurea Hypoglycaemic Agents: Part 2

  1981cites this paper
• Glucagonoma tumors and syndrome.

  1981cites this paper
• Efficacy and safety of oral hypoglycemic agents.

  1980cites this paper
• Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide

  1980cites this paper
• Hepatic Effects of Chlorpropamide: Inhibition of Glucagon-stimulated Gluconeogenesis in Perfused Livers of Fasted Rats

  1979cites this paper
• Pancreatic alpha-cell function in diabetic hemochromatotic subjects.

  1979cites this paper
• Pancreatic α-Cell Function in Diabetic Hemochromatotic Subjects*

  1979cites this paper
• [Advantages and disadvantages of insulin therapy in elderly diabetics with asymptomatic hyperglycemia].

  1979cites this paper
• Re-evaluation of phenformin therapy in maturity-onset diabetic patients.

  1979cites this paper
• Failure to Suppress Plasma Glucagon Concentrations by Orally Administered Glucose in Diabetic Patients After Treatment

  1978cites this paper
• Reference Section for C-peptide Symposium

  1978cites this paper
• Pancreatic action of the sulfonylureas.

  1977cites this paper